Richard Galperin
Foot Surgery · Dallas, TXNPI 1457311284
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Merck at 51.1% of the total. Reporting peaked in 2019 at $6,605 and has fallen 86.7% since, to $880 in 2025.
Across 179 payments — averaging $64.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$6K
- Stryker$2K
- Endo Pharmaceuticals Inc.$823
- Organogenesis Inc.$555
- Smith+Nephew$392
- Kerecis Limited$332
- plus $2K from 29 others
Across 30 payments — averaging $3382.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$54K
- Integra Lifesciences Corporation$48K
What the payments were for
- Speaking & faculty fees$4,09536%
- Travel & lodging$2,73224%
- Food & beverage$4,58640%
- Gifts$951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 21 | $5,883 |
| Stryker(2 entities) | 32 | $1,656 |
| Endo Pharmaceuticals Inc. | 9 | $823 |
| Organogenesis Inc. | 14 | $555 |
| Smith+Nephew | 25 | $392 |
| Kerecis Limited | 2 | $332 |
| Paratek Pharmaceuticals, Inc. | 12 | $230 |
| Endo USA, Inc. | 6 | $212 |
| Lifenet Health | 1 | $211 |
| Omeza LLC | 1 | $164 |
| Bone Support Inc. | 1 | $150 |
| Melinta Therapeutics, LLC | 9 | $147 |
| Orthofix Medical, Inc. | 6 | $105 |
| Misonix Inc | 3 | $65 |
| Axogen | 3 | $63 |
| Polynovo North America LLC | 3 | $53 |
| Tactile Systems Technology Inc | 3 | $48 |
| Amgen(2 entities) | 2 | $48 |
| Nabriva Therapeutics, PLC | 3 | $45 |
| KCI USA, Inc. | 3 | $37 |
| Integra Lifesciences Corporation | 3 | $33 |
| GRT US Holding, Inc. | 1 | $28 |
| Acell, Inc. | 2 | $27 |
| Sandoz | 2 | $26 |
| Sebela Pharmaceuticals Inc. | 2 | $25 |
| Nevro Corp. | 1 | $20 |
| Globus Medical | 1 | $18 |
| Averitas Pharma Inc. | 1 | $18 |
| Cashflow Solutions, LLC | 1 | $16 |
| Access Pro Medical, LLC | 1 | $16 |
| Bsn Medical Inc | 1 | $14 |
| Stability Biologics, LLC | 1 | $14 |
| Novum Pharma, LLC | 1 | $13 |
| Arteriocyte Medical Systems, Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIVEXTRO$5,668
- SALVATION$498
- Kerecis Omega3 Wound$309
- PuraPly$267
- TheraGenesis Wound Matrix$211
- CERAMENTBONE VOID FILLER$150
- CERAMENT G$150
- Viaflow$141
- ACTISHIELD CF$141
- Affinity$125
How this compares
$11,509 in reported general payments places this provider in the 85th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 68 | $1,427 |
| Gabapentin | 50 | $746 |
| Ammonium Lactate | 23 | $475 |
| Ibuprofen | 15 | $176 |
| Cephalexin | 13 | $102 |
| Meloxicam | 29 | $41 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Dallas
- Richard WeinerDallas$11K
- Jon NathansonDallas$2K
- Darlene CarterDallas$2K
- Ivan AshtonDallas$1K
- Roy AshtonDallas$707
- Scott AshtonDallas$381
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.